Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Penile Neoplasms | 12 | 2014 | 156 | 2.240 |
Why?
|
Urinary Diversion | 26 | 2011 | 134 | 1.890 |
Why?
|
Prostate | 14 | 2013 | 1755 | 0.870 |
Why?
|
Prostatic Neoplasms | 32 | 2018 | 11083 | 0.830 |
Why?
|
Ureteral Obstruction | 9 | 2011 | 291 | 0.740 |
Why?
|
Prostatectomy | 14 | 2018 | 1782 | 0.700 |
Why?
|
Penis | 6 | 2014 | 209 | 0.700 |
Why?
|
Ileum | 15 | 2009 | 558 | 0.650 |
Why?
|
Kidney Neoplasms | 17 | 2012 | 4274 | 0.630 |
Why?
|
Carcinoma, Renal Cell | 11 | 2012 | 3181 | 0.520 |
Why?
|
Prostate-Specific Antigen | 14 | 2018 | 2464 | 0.500 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2014 | 4044 | 0.490 |
Why?
|
Urinary Bladder Neoplasms | 10 | 2015 | 2176 | 0.490 |
Why?
|
Carcinoma, Transitional Cell | 8 | 2010 | 790 | 0.490 |
Why?
|
Lymph Node Excision | 8 | 2005 | 1259 | 0.480 |
Why?
|
Cystectomy | 3 | 2015 | 604 | 0.430 |
Why?
|
Perineum | 2 | 2013 | 213 | 0.420 |
Why?
|
Carcinoma, Small Cell | 1 | 2015 | 420 | 0.400 |
Why?
|
Quaternary Ammonium Compounds | 3 | 1999 | 204 | 0.400 |
Why?
|
Ureteral Neoplasms | 2 | 2010 | 106 | 0.380 |
Why?
|
Urologic Surgical Procedures, Male | 2 | 2014 | 78 | 0.360 |
Why?
|
Catheter Ablation | 8 | 2012 | 2788 | 0.350 |
Why?
|
Urinary Reservoirs, Continent | 3 | 1999 | 29 | 0.350 |
Why?
|
Kidney | 21 | 2006 | 7066 | 0.350 |
Why?
|
Biopsy | 10 | 2018 | 6763 | 0.340 |
Why?
|
Water-Electrolyte Imbalance | 3 | 2004 | 110 | 0.330 |
Why?
|
Nephrectomy | 6 | 2010 | 927 | 0.310 |
Why?
|
Acidosis | 9 | 1992 | 271 | 0.310 |
Why?
|
Lithotripsy | 3 | 2007 | 136 | 0.300 |
Why?
|
Urology | 3 | 1998 | 384 | 0.300 |
Why?
|
Neoplasm Staging | 16 | 2015 | 11206 | 0.300 |
Why?
|
Colon, Sigmoid | 4 | 2005 | 124 | 0.290 |
Why?
|
Oxides | 2 | 2008 | 402 | 0.280 |
Why?
|
Genital Diseases, Male | 3 | 2003 | 84 | 0.280 |
Why?
|
Fibroblast Growth Factors | 4 | 2004 | 871 | 0.280 |
Why?
|
Growth Substances | 2 | 1999 | 758 | 0.270 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 779 | 0.250 |
Why?
|
Hospitals, General | 1 | 2010 | 802 | 0.250 |
Why?
|
Acid-Base Imbalance | 2 | 2004 | 42 | 0.250 |
Why?
|
Cystatins | 1 | 2005 | 55 | 0.250 |
Why?
|
Surgical Flaps | 3 | 2005 | 1677 | 0.250 |
Why?
|
Glomerular Filtration Rate | 5 | 2011 | 2233 | 0.250 |
Why?
|
Acute Kidney Injury | 4 | 2005 | 1946 | 0.250 |
Why?
|
Lymphatic Metastasis | 9 | 2015 | 2887 | 0.250 |
Why?
|
Kidney Diseases | 8 | 2010 | 2098 | 0.240 |
Why?
|
Neoplasm Invasiveness | 10 | 2015 | 3602 | 0.240 |
Why?
|
Renal Insufficiency | 1 | 2011 | 804 | 0.240 |
Why?
|
Receptors, Androgen | 3 | 2008 | 1088 | 0.240 |
Why?
|
Urine | 3 | 1999 | 360 | 0.230 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2018 | 3672 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2018 | 9373 | 0.210 |
Why?
|
Electrolytes | 5 | 1991 | 280 | 0.200 |
Why?
|
Lymphedema | 2 | 2013 | 525 | 0.200 |
Why?
|
Chlorides | 6 | 1995 | 666 | 0.200 |
Why?
|
Ureter | 7 | 2011 | 364 | 0.200 |
Why?
|
Male | 97 | 2018 | 363698 | 0.190 |
Why?
|
Urinary Bladder Diseases | 3 | 1994 | 166 | 0.190 |
Why?
|
Kidney Function Tests | 6 | 2005 | 683 | 0.190 |
Why?
|
Ammonia | 5 | 2004 | 244 | 0.190 |
Why?
|
Humans | 131 | 2018 | 765968 | 0.180 |
Why?
|
Kidney Calculi | 1 | 2005 | 457 | 0.180 |
Why?
|
Intestines | 6 | 2011 | 1906 | 0.180 |
Why?
|
Metabolomics | 4 | 2018 | 1668 | 0.180 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2001 | 192 | 0.180 |
Why?
|
Iron | 2 | 2008 | 1816 | 0.180 |
Why?
|
Disease-Free Survival | 8 | 2015 | 6832 | 0.170 |
Why?
|
Groin | 3 | 2005 | 106 | 0.170 |
Why?
|
Erectile Dysfunction | 4 | 2008 | 437 | 0.170 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2005 | 622 | 0.170 |
Why?
|
Keratinocytes | 2 | 2001 | 863 | 0.160 |
Why?
|
Vagina | 1 | 2005 | 848 | 0.160 |
Why?
|
Stromal Cells | 3 | 1999 | 1329 | 0.160 |
Why?
|
Prostatic Hyperplasia | 4 | 2018 | 515 | 0.160 |
Why?
|
Patient Care Team | 1 | 2010 | 2517 | 0.160 |
Why?
|
Shock, Septic | 1 | 2005 | 774 | 0.160 |
Why?
|
Image Enhancement | 2 | 2008 | 2858 | 0.150 |
Why?
|
Kidney Pelvis | 4 | 2009 | 190 | 0.150 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1456 | 0.150 |
Why?
|
Colon | 10 | 2005 | 1795 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2004 | 687 | 0.140 |
Why?
|
Middle Aged | 53 | 2018 | 223009 | 0.140 |
Why?
|
Urologic Neoplasms | 4 | 2013 | 310 | 0.140 |
Why?
|
Urinary Bladder | 6 | 2014 | 1154 | 0.140 |
Why?
|
Lymph Nodes | 2 | 2005 | 3454 | 0.140 |
Why?
|
Urologic Diseases | 2 | 2011 | 245 | 0.140 |
Why?
|
Fibroblast Growth Factor 7 | 4 | 2004 | 59 | 0.140 |
Why?
|
Aged | 42 | 2018 | 171117 | 0.140 |
Why?
|
Minerals | 2 | 1988 | 278 | 0.140 |
Why?
|
Potassium | 6 | 1995 | 1311 | 0.140 |
Why?
|
Adenocarcinoma | 7 | 2013 | 6364 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 1 | 2005 | 1880 | 0.130 |
Why?
|
Contrast Media | 3 | 2008 | 5329 | 0.130 |
Why?
|
Hydrogen | 2 | 1995 | 168 | 0.120 |
Why?
|
Time Factors | 17 | 2015 | 40065 | 0.120 |
Why?
|
Intestinal Mucosa | 4 | 1995 | 3046 | 0.120 |
Why?
|
Cystitis | 2 | 2014 | 96 | 0.120 |
Why?
|
Intestinal Absorption | 7 | 1992 | 399 | 0.120 |
Why?
|
Gangrene | 2 | 2013 | 92 | 0.110 |
Why?
|
Nuclear Proteins | 2 | 2000 | 5783 | 0.110 |
Why?
|
Proteus mirabilis | 1 | 2014 | 24 | 0.110 |
Why?
|
Follow-Up Studies | 17 | 2018 | 39193 | 0.110 |
Why?
|
Cell Division | 4 | 2004 | 4475 | 0.110 |
Why?
|
Telangiectasis | 1 | 2014 | 77 | 0.110 |
Why?
|
Specialty Boards | 1 | 1996 | 234 | 0.110 |
Why?
|
Cecum | 2 | 1992 | 232 | 0.110 |
Why?
|
Rats, Inbred Strains | 8 | 1992 | 2077 | 0.110 |
Why?
|
Urethra | 3 | 2004 | 406 | 0.110 |
Why?
|
Sensitivity and Specificity | 6 | 2012 | 14652 | 0.110 |
Why?
|
Lymphangitis | 1 | 2013 | 15 | 0.110 |
Why?
|
Disease Progression | 7 | 2018 | 13632 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 8 | 2014 | 20659 | 0.110 |
Why?
|
Diuresis | 4 | 1986 | 107 | 0.110 |
Why?
|
Adult | 35 | 2018 | 223044 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 1998 | 830 | 0.100 |
Why?
|
Bile | 2 | 1992 | 300 | 0.100 |
Why?
|
Rats | 20 | 2008 | 23707 | 0.100 |
Why?
|
Prognosis | 11 | 2013 | 29922 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2018 | 6499 | 0.100 |
Why?
|
Urography | 3 | 2010 | 316 | 0.100 |
Why?
|
Wound Healing | 3 | 2003 | 2792 | 0.100 |
Why?
|
Survival Rate | 9 | 2013 | 12795 | 0.100 |
Why?
|
Certification | 1 | 1996 | 416 | 0.100 |
Why?
|
Mathematics | 3 | 2010 | 696 | 0.100 |
Why?
|
Laser Coagulation | 1 | 2014 | 334 | 0.100 |
Why?
|
Lasers, Solid-State | 1 | 2014 | 183 | 0.100 |
Why?
|
Sodium | 9 | 1995 | 1591 | 0.090 |
Why?
|
Retrospective Studies | 16 | 2018 | 81514 | 0.090 |
Why?
|
Citric Acid | 1 | 2012 | 124 | 0.090 |
Why?
|
Urethral Neoplasms | 2 | 2004 | 37 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2005 | 5343 | 0.090 |
Why?
|
Urinary Calculi | 2 | 2007 | 81 | 0.090 |
Why?
|
Renal Circulation | 3 | 1988 | 289 | 0.090 |
Why?
|
Androgens | 1 | 1998 | 1279 | 0.090 |
Why?
|
Urination | 2 | 2010 | 204 | 0.090 |
Why?
|
Watchful Waiting | 1 | 2015 | 493 | 0.090 |
Why?
|
Acetyltransferases | 2 | 2010 | 229 | 0.090 |
Why?
|
Retroperitoneal Fibrosis | 1 | 1991 | 39 | 0.090 |
Why?
|
Treatment Outcome | 10 | 2015 | 65188 | 0.090 |
Why?
|
Body Water | 1 | 1991 | 338 | 0.090 |
Why?
|
Ornithine Decarboxylase | 1 | 2010 | 63 | 0.090 |
Why?
|
Spermine | 1 | 2010 | 70 | 0.090 |
Why?
|
Reoperation | 4 | 2012 | 4294 | 0.090 |
Why?
|
Analysis of Variance | 3 | 2018 | 6203 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2015 | 59489 | 0.080 |
Why?
|
Dogs | 9 | 1999 | 3822 | 0.080 |
Why?
|
Hidradenitis Suppurativa | 1 | 2013 | 176 | 0.080 |
Why?
|
Hematuria | 2 | 2010 | 230 | 0.080 |
Why?
|
Fibroblast Growth Factor 10 | 2 | 1999 | 31 | 0.080 |
Why?
|
Surgery, Plastic | 2 | 1989 | 651 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1776 | 0.080 |
Why?
|
Pelvic Exenteration | 1 | 1989 | 22 | 0.080 |
Why?
|
Cystatin B | 1 | 2009 | 13 | 0.080 |
Why?
|
Postoperative Complications | 12 | 2009 | 15747 | 0.080 |
Why?
|
Skin | 1 | 2003 | 4489 | 0.080 |
Why?
|
Abdomen, Acute | 2 | 1988 | 121 | 0.080 |
Why?
|
Chlorpromazine | 2 | 1985 | 111 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2015 | 3537 | 0.080 |
Why?
|
Phentolamine | 1 | 1988 | 102 | 0.080 |
Why?
|
Magnesium | 2 | 1989 | 813 | 0.080 |
Why?
|
Papaverine | 1 | 1988 | 45 | 0.080 |
Why?
|
Gene Amplification | 1 | 2013 | 1091 | 0.080 |
Why?
|
RNA, Messenger | 4 | 2010 | 12768 | 0.070 |
Why?
|
Treatment Failure | 2 | 2011 | 2652 | 0.070 |
Why?
|
Bone and Bones | 2 | 1988 | 2554 | 0.070 |
Why?
|
Penile Erection | 1 | 1988 | 100 | 0.070 |
Why?
|
Ferrosoferric Oxide | 2 | 2008 | 349 | 0.070 |
Why?
|
Sulfates | 1 | 1989 | 376 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2014 | 12976 | 0.070 |
Why?
|
Magnetite Nanoparticles | 2 | 2008 | 309 | 0.070 |
Why?
|
Dextrans | 2 | 2008 | 571 | 0.070 |
Why?
|
Propylene Glycols | 1 | 2007 | 91 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 8 | 2009 | 36532 | 0.070 |
Why?
|
Models, Organizational | 1 | 2010 | 547 | 0.070 |
Why?
|
Radiation Injuries | 1 | 2014 | 1181 | 0.070 |
Why?
|
Cells, Cultured | 5 | 2001 | 18973 | 0.070 |
Why?
|
Urogenital Neoplasms | 1 | 2008 | 129 | 0.070 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2010 | 499 | 0.070 |
Why?
|
Biological Transport | 6 | 1992 | 2081 | 0.070 |
Why?
|
Laparoscopy | 2 | 2009 | 2039 | 0.070 |
Why?
|
Lymphangioma | 1 | 1986 | 60 | 0.060 |
Why?
|
Osmolar Concentration | 6 | 1986 | 655 | 0.060 |
Why?
|
Gastric Mucosa | 2 | 2004 | 602 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2004 | 1534 | 0.060 |
Why?
|
General Surgery | 1 | 1997 | 1722 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 1276 | 0.060 |
Why?
|
Microvilli | 2 | 1997 | 234 | 0.060 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1600 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2010 | 697 | 0.060 |
Why?
|
Boston | 3 | 2015 | 9338 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15398 | 0.060 |
Why?
|
Immunohistochemistry | 5 | 2008 | 11022 | 0.060 |
Why?
|
Epithelial Cells | 3 | 2004 | 3681 | 0.060 |
Why?
|
Pyelonephritis | 1 | 1985 | 77 | 0.060 |
Why?
|
Reflex, Abnormal | 1 | 2005 | 83 | 0.060 |
Why?
|
Creatinine | 4 | 2005 | 1915 | 0.060 |
Why?
|
Fecal Incontinence | 1 | 2008 | 245 | 0.060 |
Why?
|
Combined Modality Therapy | 3 | 2014 | 8529 | 0.060 |
Why?
|
Salvage Therapy | 1 | 2011 | 1272 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 4 | 1995 | 2477 | 0.060 |
Why?
|
Carcinoma | 3 | 2013 | 2312 | 0.060 |
Why?
|
Ketorolac | 1 | 2005 | 95 | 0.060 |
Why?
|
Scrotum | 2 | 1983 | 115 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2013 | 20124 | 0.060 |
Why?
|
Hydronephrosis | 3 | 1981 | 274 | 0.060 |
Why?
|
Animals | 33 | 2011 | 168764 | 0.060 |
Why?
|
Niacin | 1 | 1985 | 116 | 0.060 |
Why?
|
Palladium | 1 | 2004 | 67 | 0.060 |
Why?
|
Amiloride | 2 | 1995 | 115 | 0.060 |
Why?
|
Cosmetics | 1 | 2005 | 102 | 0.060 |
Why?
|
Cystatin C | 1 | 2005 | 272 | 0.060 |
Why?
|
Abscess | 2 | 1985 | 606 | 0.060 |
Why?
|
Nanostructures | 2 | 2005 | 548 | 0.050 |
Why?
|
Urinary Incontinence | 1 | 2008 | 491 | 0.050 |
Why?
|
Risk | 2 | 2005 | 9591 | 0.050 |
Why?
|
Genital Neoplasms, Male | 1 | 2003 | 68 | 0.050 |
Why?
|
Risk Factors | 7 | 2015 | 74840 | 0.050 |
Why?
|
Radioisotopes | 1 | 2004 | 495 | 0.050 |
Why?
|
Female | 43 | 2015 | 396112 | 0.050 |
Why?
|
Urinary Tract Infections | 3 | 1985 | 805 | 0.050 |
Why?
|
Leuprolide | 1 | 2004 | 312 | 0.050 |
Why?
|
Clinical Competence | 1 | 1998 | 4863 | 0.050 |
Why?
|
Liver | 6 | 2004 | 7562 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2008 | 8102 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2008 | 802 | 0.050 |
Why?
|
Activins | 1 | 2004 | 210 | 0.050 |
Why?
|
Burns | 4 | 1979 | 1903 | 0.050 |
Why?
|
Neoplasm Metastasis | 4 | 2008 | 4893 | 0.050 |
Why?
|
Radionuclide Imaging | 4 | 2012 | 1978 | 0.050 |
Why?
|
Jejunum | 1 | 2004 | 474 | 0.050 |
Why?
|
Stomach | 2 | 2004 | 699 | 0.050 |
Why?
|
Recovery of Function | 2 | 2009 | 2966 | 0.050 |
Why?
|
Reperfusion Injury | 1 | 1988 | 1042 | 0.050 |
Why?
|
Cohort Studies | 4 | 2015 | 41649 | 0.050 |
Why?
|
Indomethacin | 1 | 1982 | 322 | 0.050 |
Why?
|
Ultrasonography | 4 | 2006 | 5993 | 0.050 |
Why?
|
Captopril | 1 | 1982 | 261 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12509 | 0.050 |
Why?
|
Acid-Base Equilibrium | 3 | 1991 | 180 | 0.050 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1188 | 0.050 |
Why?
|
Epithelium | 2 | 2012 | 1599 | 0.050 |
Why?
|
Flutamide | 1 | 2001 | 96 | 0.050 |
Why?
|
Uremia | 2 | 1991 | 202 | 0.040 |
Why?
|
Testicular Neoplasms | 2 | 2005 | 786 | 0.040 |
Why?
|
Proline | 1 | 1982 | 453 | 0.040 |
Why?
|
Bone Diseases, Metabolic | 1 | 2004 | 407 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2008 | 1727 | 0.040 |
Why?
|
Urodynamics | 3 | 1987 | 349 | 0.040 |
Why?
|
Temperature | 1 | 2007 | 2226 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2005 | 1187 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2001 | 220 | 0.040 |
Why?
|
Calcium | 3 | 1989 | 5767 | 0.040 |
Why?
|
Remission Induction | 1 | 2005 | 2411 | 0.040 |
Why?
|
Methods | 3 | 1992 | 1052 | 0.040 |
Why?
|
Endotoxins | 2 | 1978 | 516 | 0.040 |
Why?
|
Heparin | 1 | 1986 | 1630 | 0.040 |
Why?
|
Syndrome | 1 | 2005 | 3271 | 0.040 |
Why?
|
Forecasting | 2 | 1998 | 2936 | 0.040 |
Why?
|
Urinary Catheterization | 2 | 1992 | 195 | 0.040 |
Why?
|
Bone Diseases | 2 | 1992 | 411 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4562 | 0.040 |
Why?
|
Bicarbonates | 3 | 1991 | 293 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 1998 | 222 | 0.040 |
Why?
|
Keratins | 1 | 1999 | 498 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 1999 | 419 | 0.040 |
Why?
|
Teaching Materials | 1 | 1998 | 85 | 0.040 |
Why?
|
Vena Cava, Inferior | 2 | 1991 | 463 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 1980 | 354 | 0.040 |
Why?
|
Glucose | 6 | 1992 | 4335 | 0.040 |
Why?
|
Antibody Specificity | 1 | 1999 | 1061 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 1999 | 522 | 0.040 |
Why?
|
Organ Size | 3 | 2011 | 2260 | 0.040 |
Why?
|
Membranes | 1 | 1977 | 164 | 0.030 |
Why?
|
Sodium Bicarbonate | 2 | 1988 | 59 | 0.030 |
Why?
|
Brachytherapy | 1 | 2004 | 1222 | 0.030 |
Why?
|
Principal Component Analysis | 2 | 2010 | 951 | 0.030 |
Why?
|
Radiography | 3 | 2006 | 6919 | 0.030 |
Why?
|
Kallikreins | 1 | 2018 | 220 | 0.030 |
Why?
|
Mucous Membrane | 2 | 2014 | 657 | 0.030 |
Why?
|
Inulin | 3 | 1985 | 67 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2000 | 415 | 0.030 |
Why?
|
Culture Media | 1 | 1998 | 890 | 0.030 |
Why?
|
Kidney Failure, Chronic | 2 | 1986 | 2495 | 0.030 |
Why?
|
Nanoparticles | 1 | 2008 | 1964 | 0.030 |
Why?
|
Nitrogen | 1 | 1977 | 346 | 0.030 |
Why?
|
Acridine Orange | 1 | 1995 | 28 | 0.030 |
Why?
|
Parenteral Nutrition | 2 | 1977 | 660 | 0.030 |
Why?
|
Acid Phosphatase | 1 | 1976 | 139 | 0.030 |
Why?
|
Kidney Tubules | 3 | 1990 | 453 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2011 | 18293 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3529 | 0.030 |
Why?
|
Hospitals, University | 1 | 1997 | 574 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2268 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 1981 | 2228 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2012 | 12056 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 5995 | 0.030 |
Why?
|
Lung | 1 | 2014 | 10033 | 0.030 |
Why?
|
Bumetanide | 1 | 1995 | 101 | 0.030 |
Why?
|
History, 19th Century | 1 | 1997 | 711 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2000 | 1229 | 0.030 |
Why?
|
Chronic Disease | 1 | 2010 | 9347 | 0.030 |
Why?
|
Vacuoles | 1 | 1995 | 224 | 0.030 |
Why?
|
Cause of Death | 1 | 2005 | 3708 | 0.030 |
Why?
|
Age Factors | 3 | 2011 | 18380 | 0.030 |
Why?
|
Ion Transport | 1 | 1995 | 322 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2010 | 10429 | 0.030 |
Why?
|
Carcinoid Tumor | 1 | 1976 | 225 | 0.030 |
Why?
|
Primary Health Care | 1 | 2011 | 4736 | 0.030 |
Why?
|
Technetium | 2 | 1986 | 326 | 0.030 |
Why?
|
Child | 9 | 2007 | 80564 | 0.030 |
Why?
|
Laser Therapy | 1 | 2000 | 1108 | 0.030 |
Why?
|
Prostatic Diseases | 2 | 1986 | 55 | 0.030 |
Why?
|
Radiography, Interventional | 3 | 2005 | 1129 | 0.030 |
Why?
|
Fluorescence | 1 | 1995 | 753 | 0.030 |
Why?
|
Length of Stay | 2 | 2005 | 6485 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1980 | 1127 | 0.030 |
Why?
|
Ammonium Chloride | 2 | 1991 | 72 | 0.030 |
Why?
|
Ion Exchange | 1 | 1972 | 16 | 0.030 |
Why?
|
Barium | 1 | 1992 | 62 | 0.030 |
Why?
|
Peritonitis | 1 | 1975 | 369 | 0.030 |
Why?
|
Urinary Fistula | 1 | 1972 | 44 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2001 | 1411 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2844 | 0.020 |
Why?
|
Up-Regulation | 1 | 2001 | 4137 | 0.020 |
Why?
|
Blotting, Western | 1 | 1999 | 5020 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2004 | 2567 | 0.020 |
Why?
|
Duodenal Diseases | 1 | 1972 | 101 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2005 | 3800 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2004 | 3564 | 0.020 |
Why?
|
Urease | 1 | 1991 | 43 | 0.020 |
Why?
|
Furosemide | 1 | 1992 | 175 | 0.020 |
Why?
|
Intestinal Fistula | 1 | 1972 | 146 | 0.020 |
Why?
|
Dimethyl Sulfoxide | 1 | 1992 | 251 | 0.020 |
Why?
|
Gastric Juice | 1 | 1971 | 59 | 0.020 |
Why?
|
Adolescent | 9 | 2005 | 88835 | 0.020 |
Why?
|
Microelectrodes | 1 | 1972 | 304 | 0.020 |
Why?
|
Kidney Concentrating Ability | 2 | 1991 | 34 | 0.020 |
Why?
|
Metabolome | 1 | 2018 | 1005 | 0.020 |
Why?
|
Methylprednisolone | 1 | 1992 | 386 | 0.020 |
Why?
|
Anastomosis, Surgical | 2 | 2011 | 990 | 0.020 |
Why?
|
Intestine, Small | 1 | 1997 | 1214 | 0.020 |
Why?
|
Hematoma | 1 | 1975 | 766 | 0.020 |
Why?
|
Iodobenzoates | 1 | 1990 | 10 | 0.020 |
Why?
|
Ribs | 1 | 2012 | 254 | 0.020 |
Why?
|
Meningomyelocele | 1 | 1992 | 182 | 0.020 |
Why?
|
Retroperitoneal Space | 1 | 1991 | 173 | 0.020 |
Why?
|
Growth | 1 | 1992 | 365 | 0.020 |
Why?
|
Kidney Tubules, Distal | 3 | 1976 | 43 | 0.020 |
Why?
|
Cell Membrane | 2 | 1995 | 3634 | 0.020 |
Why?
|
Prednisolone | 1 | 1991 | 324 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 1990 | 124 | 0.020 |
Why?
|
Prospective Studies | 4 | 2009 | 54802 | 0.020 |
Why?
|
Ultrasonics | 1 | 1990 | 209 | 0.020 |
Why?
|
Intestinal Neoplasms | 1 | 1992 | 313 | 0.020 |
Why?
|
History, 20th Century | 1 | 1997 | 2761 | 0.020 |
Why?
|
Recurrence | 4 | 2009 | 8501 | 0.020 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 1991 | 161 | 0.020 |
Why?
|
Azathioprine | 1 | 1991 | 350 | 0.020 |
Why?
|
Urea | 2 | 1985 | 448 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2004 | 5337 | 0.020 |
Why?
|
Acidosis, Renal Tubular | 1 | 1989 | 50 | 0.020 |
Why?
|
Transcription Factors | 1 | 2008 | 12131 | 0.020 |
Why?
|
Educational Measurement | 1 | 1996 | 1260 | 0.020 |
Why?
|
Sigmoid Neoplasms | 1 | 1989 | 54 | 0.020 |
Why?
|
Massachusetts | 2 | 2000 | 8875 | 0.020 |
Why?
|
Femoral Nerve | 1 | 2008 | 43 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 10383 | 0.020 |
Why?
|
Linear Models | 1 | 1998 | 5876 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 59889 | 0.020 |
Why?
|
Immunotherapy | 1 | 2004 | 4752 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2008 | 381 | 0.020 |
Why?
|
Indocyanine Green | 3 | 1978 | 235 | 0.020 |
Why?
|
Skull | 1 | 2012 | 811 | 0.020 |
Why?
|
Calcium Sulfate | 1 | 2007 | 24 | 0.020 |
Why?
|
Membrane Potentials | 3 | 1978 | 1083 | 0.020 |
Why?
|
Phosphorus | 1 | 1988 | 337 | 0.020 |
Why?
|
Amino Acids | 3 | 1978 | 1709 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2009 | 399 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 2008 | 2548 | 0.020 |
Why?
|
Rectal Neoplasms | 1 | 1976 | 1182 | 0.020 |
Why?
|
Calcium Oxalate | 1 | 2007 | 75 | 0.020 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1986 | 67 | 0.020 |
Why?
|
Sepsis | 2 | 1977 | 2606 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2004 | 11641 | 0.020 |
Why?
|
Pentetic Acid | 1 | 1986 | 208 | 0.020 |
Why?
|
Suppuration | 1 | 1985 | 61 | 0.020 |
Why?
|
Lasers | 1 | 2010 | 951 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 1991 | 1090 | 0.020 |
Why?
|
Solubility | 1 | 2007 | 1078 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 1988 | 657 | 0.020 |
Why?
|
Incidence | 3 | 2012 | 21480 | 0.010 |
Why?
|
Kidney Tubules, Collecting | 1 | 2005 | 163 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4618 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 995 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 2045 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 17075 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1991 | 950 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 1992 | 1084 | 0.010 |
Why?
|
Thymidine | 1 | 2004 | 294 | 0.010 |
Why?
|
Cystoscopy | 1 | 2004 | 128 | 0.010 |
Why?
|
Liver Diseases | 1 | 1992 | 1303 | 0.010 |
Why?
|
Materials Testing | 1 | 2007 | 868 | 0.010 |
Why?
|
Pilot Projects | 2 | 2008 | 8733 | 0.010 |
Why?
|
Mycobacterium bovis | 1 | 2004 | 148 | 0.010 |
Why?
|
Rupture, Spontaneous | 2 | 1975 | 359 | 0.010 |
Why?
|
Collagen Diseases | 1 | 1983 | 38 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2008 | 2120 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2008 | 1735 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 2006 | 13451 | 0.010 |
Why?
|
United States | 3 | 2012 | 72903 | 0.010 |
Why?
|
Hypertrophy | 1 | 1984 | 559 | 0.010 |
Why?
|
Kidney Tubules, Proximal | 2 | 1976 | 386 | 0.010 |
Why?
|
Skin Diseases, Infectious | 1 | 1983 | 73 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3620 | 0.010 |
Why?
|
Warfarin | 1 | 1991 | 1494 | 0.010 |
Why?
|
Thigh | 1 | 1983 | 238 | 0.010 |
Why?
|
Pelvis | 1 | 1986 | 738 | 0.010 |
Why?
|
Drug Combinations | 1 | 1988 | 2077 | 0.010 |
Why?
|
p-Aminohippuric Acid | 1 | 1981 | 36 | 0.010 |
Why?
|
Succimer | 1 | 1981 | 29 | 0.010 |
Why?
|
Hyperplasia | 1 | 1984 | 1144 | 0.010 |
Why?
|
Urologic Surgical Procedures | 1 | 2004 | 281 | 0.010 |
Why?
|
Thrombosis | 2 | 1991 | 2949 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2010 | 2475 | 0.010 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 1 | 1981 | 82 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1985 | 1467 | 0.010 |
Why?
|
Radiotherapy, Conformal | 1 | 2004 | 533 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1986 | 1628 | 0.010 |
Why?
|
Necrosis | 1 | 2005 | 1617 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1981 | 360 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1991 | 6309 | 0.010 |
Why?
|
Wounds and Injuries | 2 | 1992 | 2511 | 0.010 |
Why?
|
Transfection | 1 | 2008 | 5743 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4255 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 1980 | 189 | 0.010 |
Why?
|
Child, Preschool | 5 | 1992 | 42500 | 0.010 |
Why?
|
Pyrimidines | 1 | 1992 | 3047 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2005 | 1009 | 0.010 |
Why?
|
Testis | 1 | 1983 | 780 | 0.010 |
Why?
|
Cholesteatoma | 1 | 1979 | 28 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3421 | 0.010 |
Why?
|
Bone Density | 1 | 1992 | 3491 | 0.010 |
Why?
|
Blood Volume | 1 | 1980 | 542 | 0.010 |
Why?
|
Toxemia | 1 | 1978 | 14 | 0.010 |
Why?
|
Telomerase | 1 | 2004 | 749 | 0.010 |
Why?
|
Bacteriuria | 1 | 1979 | 102 | 0.010 |
Why?
|
Signal Transduction | 1 | 2001 | 23601 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 1978 | 323 | 0.010 |
Why?
|
Cost of Illness | 1 | 2008 | 1950 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 2004 | 708 | 0.010 |
Why?
|
Penile Diseases | 1 | 1978 | 47 | 0.010 |
Why?
|
Cisplatin | 1 | 2004 | 1658 | 0.010 |
Why?
|
Homeostasis | 1 | 1989 | 3336 | 0.010 |
Why?
|
Angiography | 1 | 1983 | 1581 | 0.010 |
Why?
|
Microsurgery | 1 | 1983 | 795 | 0.010 |
Why?
|
Graft Survival | 1 | 2008 | 3890 | 0.010 |
Why?
|
Lactates | 1 | 1978 | 398 | 0.010 |
Why?
|
Sodium Chloride | 2 | 1972 | 576 | 0.010 |
Why?
|
Vasculitis | 1 | 1981 | 527 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5302 | 0.010 |
Why?
|
Fats | 1 | 1977 | 99 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13266 | 0.010 |
Why?
|
Swine | 1 | 2007 | 5988 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2000 | 636 | 0.010 |
Why?
|
Gastrointestinal Diseases | 2 | 1983 | 1203 | 0.010 |
Why?
|
Rectal Diseases | 1 | 1978 | 141 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1976 | 167 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3807 | 0.010 |
Why?
|
Diet Therapy | 1 | 1977 | 149 | 0.010 |
Why?
|
Surgical Tape | 1 | 1956 | 5 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 1652 | 0.010 |
Why?
|
Kidney Medulla | 1 | 1976 | 169 | 0.010 |
Why?
|
Colonic Diseases | 1 | 1978 | 204 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2004 | 6113 | 0.010 |
Why?
|
Renal Dialysis | 1 | 1985 | 1799 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1976 | 696 | 0.010 |
Why?
|
Hyaline Membrane Disease | 1 | 1975 | 19 | 0.010 |
Why?
|
Renal Veins | 1 | 1975 | 103 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2000 | 2910 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7425 | 0.010 |
Why?
|
Rabbits | 1 | 1981 | 4734 | 0.010 |
Why?
|
Vascular Diseases | 1 | 1983 | 1159 | 0.010 |
Why?
|
RNA | 1 | 1984 | 2717 | 0.010 |
Why?
|
Coloring Agents | 1 | 1977 | 564 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7599 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6069 | 0.010 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 1975 | 94 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 1983 | 1485 | 0.010 |
Why?
|
Kidney Glomerulus | 1 | 1976 | 568 | 0.010 |
Why?
|
Antineoplastic Agents | 2 | 2009 | 13648 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1975 | 325 | 0.010 |
Why?
|
Sutures | 1 | 1956 | 284 | 0.010 |
Why?
|
Hemorrhage | 2 | 1990 | 3461 | 0.010 |
Why?
|
Loop of Henle | 1 | 1972 | 38 | 0.010 |
Why?
|
Hernia, Inguinal | 1 | 1956 | 224 | 0.010 |
Why?
|
Energy Intake | 2 | 1977 | 2141 | 0.010 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 1972 | 82 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 22223 | 0.010 |
Why?
|
Mannitol | 1 | 1972 | 176 | 0.010 |
Why?
|
Phenolsulfonphthalein | 1 | 1991 | 3 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1972 | 229 | 0.010 |
Why?
|
Ligation | 1 | 1972 | 444 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1978 | 1870 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 1975 | 544 | 0.010 |
Why?
|
Gastric Acidity Determination | 1 | 1971 | 56 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6322 | 0.010 |
Why?
|
Nephrotic Syndrome | 1 | 1975 | 380 | 0.010 |
Why?
|
DNA | 1 | 1984 | 7202 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 3540 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15842 | 0.010 |
Why?
|
Permeability | 1 | 1972 | 726 | 0.010 |
Why?
|
Obesity | 1 | 2012 | 13076 | 0.010 |
Why?
|
Insulin | 3 | 1978 | 6599 | 0.010 |
Why?
|
Iohexol | 1 | 1990 | 204 | 0.000 |
Why?
|
Mutation | 1 | 2013 | 30198 | 0.000 |
Why?
|
Wilms Tumor | 1 | 1991 | 379 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1991 | 1526 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1990 | 1377 | 0.000 |
Why?
|
Pressure | 1 | 1990 | 1168 | 0.000 |
Why?
|
Postoperative Period | 1 | 1991 | 1816 | 0.000 |
Why?
|
Perfusion | 1 | 1991 | 1407 | 0.000 |
Why?
|
Wounds, Gunshot | 1 | 1972 | 585 | 0.000 |
Why?
|
Water | 1 | 1972 | 1417 | 0.000 |
Why?
|
Sex Factors | 2 | 1983 | 10603 | 0.000 |
Why?
|
Lung Injury | 1 | 1990 | 430 | 0.000 |
Why?
|
Infant | 2 | 1980 | 36386 | 0.000 |
Why?
|
Comorbidity | 1 | 2000 | 10563 | 0.000 |
Why?
|
Cystic Fibrosis | 1 | 1975 | 1287 | 0.000 |
Why?
|
Renal Artery Obstruction | 1 | 1986 | 218 | 0.000 |
Why?
|
Hypertension, Renal | 1 | 1985 | 131 | 0.000 |
Why?
|
Models, Biological | 1 | 1981 | 9443 | 0.000 |
Why?
|
Blood Transfusion | 1 | 1991 | 1297 | 0.000 |
Why?
|
Bacteria | 1 | 1975 | 2209 | 0.000 |
Why?
|
Pneumonia | 1 | 1975 | 2157 | 0.000 |
Why?
|
Renin | 1 | 1985 | 647 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1985 | 574 | 0.000 |
Why?
|
Digestive System | 1 | 1983 | 244 | 0.000 |
Why?
|
Random Allocation | 1 | 1986 | 2395 | 0.000 |
Why?
|
Rectum | 1 | 1986 | 896 | 0.000 |
Why?
|
Heart Arrest | 1 | 1991 | 1516 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 1976 | 4353 | 0.000 |
Why?
|
Endoplasmic Reticulum | 1 | 1985 | 1132 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1986 | 1275 | 0.000 |
Why?
|
Parenteral Nutrition, Total | 1 | 1977 | 304 | 0.000 |
Why?
|
Typhoid Fever | 1 | 1977 | 197 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1990 | 12437 | 0.000 |
Why?
|
Growth Hormone | 1 | 1977 | 566 | 0.000 |
Why?
|
Debridement | 1 | 1978 | 495 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1975 | 26346 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2000 | 21056 | 0.000 |
Why?
|
Muscles | 1 | 1977 | 1578 | 0.000 |
Why?
|
Dietary Carbohydrates | 1 | 1977 | 894 | 0.000 |
Why?
|
Dietary Proteins | 1 | 1977 | 959 | 0.000 |
Why?
|
Dietary Fats | 1 | 1977 | 2002 | 0.000 |
Why?
|
Energy Metabolism | 1 | 1977 | 2892 | 0.000 |
Why?
|